Constantin Volovăț
Impact in
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Gastroenterology top 5%
- Gastrointestinal Tumor Research and Treatment
Papers in
- Oncology 24
- Colorectal Cancer Treatments and Studies 6
- Neutropenia and Cancer Infections 5
-
- Lung Cancer Treatments and Mutations 4
- Gastric Cancer Management and Outcomes 3
- Co-authors
- Vladimir Moiseyenko (2 shared papers)Pamela Salman (2 shared papers)Akira Sawaki (2 shared papers)Helena Melezínková (2 shared papers)В. А. Горбунова (2 shared papers)G. Kurteva (2 shared papers)Sang Cheul Oh (2 shared papers)Yoon‐Koo Kang (2 shared papers)
In The Last Decade
Constantin Volovăț
43 papers receiving 1.4k citations
Constantin Volovăț's Hit Papers
Peers
Comparison fields: 5 of 83
- Oncology 672
- Gastroenterology 134
- Pulmonary and Respiratory Medicine 538
- Cancer Research 148
- Pathology and Forensic Medicine 153
Countries citing papers authored by Constantin Volovăț
This map shows the geographic impact of Constantin Volovăț's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Constantin Volovăț with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Constantin Volovăț more than expected).
Fields of papers citing papers by Constantin Volovăț
This network shows the impact of papers produced by Constantin Volovăț. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Constantin Volovăț. The network helps show where Constantin Volovăț may publish in the future.
Co-authors
The 25 scholars most cited alongside Constantin Volovăț, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial Hit paper breakdown → | 2013 | 640 |
| 2 | 2008 | 190 | |
| 3 | 2020 | 103 | |
| 4 | 2010 | 67 | |
| 5 | 2024 | 40 | |
| 6 | 2014 | 33 | |
| 7 | 2013 | 27 | |
| 8 | 2020 | 24 | |
| 9 | 2020 | 23 | |
| 10 | 2022 | 23 | |
| 11 | 2007 | 23 | |
| 12 | 2013 | 22 | |
| 13 | 2015 | 17 | |
| 14 | 2014 | 16 | |
| 15 | 2022 | 16 | |
| 16 | 2021 | 11 | |
| 17 | 2022 | 11 | |
| 18 | 2021 | 10 | |
| 19 | 2020 | 8 | |
| 20 | 2015 | 8 |
About Constantin Volovăț
Constantin Volovăț is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 46 papers that have together received 1.4k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (6 papers), Neutropenia and Cancer Infections (5 papers), Lung Cancer Treatments and Mutations (4 papers), Nanoplatforms for cancer theranostics (4 papers), Surfactants and Colloidal Systems (3 papers), Immunotherapy and Immune Responses (3 papers), Gastric Cancer Management and Outcomes (3 papers) and Head and Neck Cancer Studies (3 papers). The work is most often cited by research in Oncology (672 citations), Gastroenterology (134 citations), Pulmonary and Respiratory Medicine (538 citations), Cancer Research (148 citations) and Pathology and Forensic Medicine (153 citations). Constantin Volovăț has collaborated with scholars based in Romania, Russia and Germany. Frequent co-authors include Vladimir Moiseyenko, Pamela Salman, Akira Sawaki, Helena Melezínková, В. А. Горбунова, G. Kurteva, Sang Cheul Oh, Yoon‐Koo Kang, Florian Lordick and Markus Moehler. Their work appears in journals such as Journal of Clinical Oncology, Pharmaceutics, Drug Delivery, International Journal of Molecular Sciences and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.